open access

Vol 6, No 5 (2017)
Original articles (submitted)
Published online: 2017-12-28
Get Citation

Beta-endorphin levels in both painful and painless diabetic peripheral neuropathy and its relations to pain characters and severity

Enas T. Elkhamisy, Mayada S. Khalel, Azza A. Elbioumy, Mamdouh R. Elnahas
DOI: 10.5603/DK.2017.0027
·
Clinical Diabetology 2017;6(5):159-171.

open access

Vol 6, No 5 (2017)
Original articles (submitted)
Published online: 2017-12-28

Abstract

Introduction. In the peripheral nervous system (PNS), beta-endorphins produce analgesia by binding to opioid receptors (particularly of the mu subtype) at both preand post-synaptic nerve terminals, primarily exerting their effect through presynaptic binding. Aim was to study serum beta-endorphin levels in diabetic patients with and without diabetic peripheral neuropathy and its relations to characters and severity of pain in patients with painful diabetic peripheral neuropathy. Material and methods. The study was a case control study including 88 participants; 73 diabetics and 15 age and sex matched healthy subjects. For all subjects, levels of HbA1c, serum creatinine, total cholesterol, triglycerides, HDL and LDL as well as serum levels of beta-endorphin were measured. Pain severity was detected by using visual analogue pain scale. Results. Serum beta-endorphin shows no significant difference between diabetic neuropathic, diabetic non neuropathic and control groups (p = 0.275). Serum beta-endorphin shows negative correlation with age (p = 0.049) and HbA1c (p = 0.048). While it was not correlated with pain severity (p = 0.371), NDS: total score (p = 0.803), BMI (p = 0.801), serum creatinine (p = 0.074) or DM duration (p = 0.607). Serum beta-endorphin shows no significant difference between painful and painless neuropathy subgroups (p = 0.701). Conclusion. In our study serum beta-endorphin levels showed no significant difference between patients with painless diabetic peripheral neuropathy and those with painful diabetic peripheral neuropathy with different characters of pain. Also, serum beta-endorphin levels was not correlated with pain severity.

Abstract

Introduction. In the peripheral nervous system (PNS), beta-endorphins produce analgesia by binding to opioid receptors (particularly of the mu subtype) at both preand post-synaptic nerve terminals, primarily exerting their effect through presynaptic binding. Aim was to study serum beta-endorphin levels in diabetic patients with and without diabetic peripheral neuropathy and its relations to characters and severity of pain in patients with painful diabetic peripheral neuropathy. Material and methods. The study was a case control study including 88 participants; 73 diabetics and 15 age and sex matched healthy subjects. For all subjects, levels of HbA1c, serum creatinine, total cholesterol, triglycerides, HDL and LDL as well as serum levels of beta-endorphin were measured. Pain severity was detected by using visual analogue pain scale. Results. Serum beta-endorphin shows no significant difference between diabetic neuropathic, diabetic non neuropathic and control groups (p = 0.275). Serum beta-endorphin shows negative correlation with age (p = 0.049) and HbA1c (p = 0.048). While it was not correlated with pain severity (p = 0.371), NDS: total score (p = 0.803), BMI (p = 0.801), serum creatinine (p = 0.074) or DM duration (p = 0.607). Serum beta-endorphin shows no significant difference between painful and painless neuropathy subgroups (p = 0.701). Conclusion. In our study serum beta-endorphin levels showed no significant difference between patients with painless diabetic peripheral neuropathy and those with painful diabetic peripheral neuropathy with different characters of pain. Also, serum beta-endorphin levels was not correlated with pain severity.
Get Citation

Keywords

endorfin; diabetes; neuropathy

About this article
Title

Beta-endorphin levels in both painful and painless diabetic peripheral neuropathy and its relations to pain characters and severity

Journal

Clinical Diabetology

Issue

Vol 6, No 5 (2017)

Pages

159-171

Published online

2017-12-28

DOI

10.5603/DK.2017.0027

Bibliographic record

Clinical Diabetology 2017;6(5):159-171.

Keywords

endorfin
diabetes
neuropathy

Authors

Enas T. Elkhamisy
Mayada S. Khalel
Azza A. Elbioumy
Mamdouh R. Elnahas

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl